Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 May 2008, Vol. 111, No. 10, pp. 5008-5016.
Prepublished online as a Blood First Edition Paper on March 4, 2008; DOI 10.1182/blood-2007-11-122259.


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Figure
Right arrow All Versions of this Article:
blood-2007-11-122259v1
111/10/5008    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guia, S.
Right arrow Articles by Vivier, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guia, S.
Right arrow Articles by Vivier, E.
Related Collections
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

IMMUNOBIOLOGY

A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo

Sophie Guia13, Céline Cognet14, Ludovic de Beaucoudrey5,6, Marlowe S. Tessmer7, Emmanuelle Jouanguy5,6, Claire Berger8, Orchidée Filipe-Santos5,6, Jacqueline Feinberg5,6, Yildiz Camcioglu9, Jacob Levy10, Suliman Al Jumaah11, Sami Al-Hajjar11, Jean-Louis Stephan8, Claire Fieschi12, Laurent Abel5,6, Laurent Brossay7, Jean-Laurent Casanova5,6,13, and Eric Vivier14

1 Centre d'Immunologie de Marseille-Luminy, Université de la Méditerranée, Marseille, France; 2 Inserm U631, Marseille, France; 3 Centre National de la Recherche Scientifique (CNRS), UMR6102, Marseille, France; 4 Hôpital de la Conception, Assistance Publique–Hôpitaux de Marseille, Marseille, France; 5 Laboratoire de Génétique Humaine des Maladies Infectieuses, Inserm U550, Paris, France; 6 Université Paris René Descartes, Faculté de Médecine Necker, Paris, France; 7 Department of Molecular Microbiology and Immunology, Brown University, Providence, RI; 8 Service de Pédiatrie, Centre Hospitalier Universitaire (CHU), St Etienne, France; 9 Department of Pediatrics, Infectious Diseases, Clinical Immunology and Allergy Division, Cerrahpaçsa Medical School, Istanbul University, Istanbul, Turkey; 10 Pediatric Department, Soroka Medical Center, Faculty of Health Sciences, Ben Gurion University, Beer Sheva, Israel; 11 Department of Pediatrics, King Faysal Hospital and Research Center, Riyadh, Saudi Arabia; 12 Service d'Immunopathologie, Hôpital Saint-Louis, Paris, France; and 13 Unité d'Immuno-Hématologie, Hôpital Necker, Paris, France

Natural killer (NK) cells have been originally defined by their "naturally occurring" effector function. However, only a fraction of human NK cells is reactive toward a panel of prototypical tumor cell targets in vitro, both for the production of interferon-{gamma} (IFN-{gamma}) and for their cytotoxic response. In patients with IL12RB1 mutations that lead to a complete IL-12Rβ1 deficiency, the size of this naturally reactive NK cell subset is diminished, in particular for the IFN-{gamma} production. Similar data were obtained from a patient with a complete deficit in IL-12p40. In addition, the size of the subset of effector memory T cells expressing CD56 was severely decreased in IL-12Rβ1– and IL-12p40–deficient patients. Human NK cells thus require in vivo priming with IL-12/23 to acquire their full spectrum of functional reactivity, while T cells are dependent upon IL-12/23 signals for the differentiation and/or the maintenance of CD56+ effector memory T cells. The susceptibility of IL-12/23 axis–deficient patients to Mycobacterium and Salmonella infections in combination with the absence of mycobacteriosis or salmonellosis in the rare cases of human NK cell deficiencies point to a role for CD56+ T cells in the control of these infections in humans.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
N. Lapaque, T. Walzer, S. Meresse, E. Vivier, and J. Trowsdale
Interactions between Human NK Cells and Macrophages in Response to Salmonella Infection
J. Immunol., April 1, 2009; 182(7): 4339 - 4348.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
D. van de Wetering, R. A. de Paus, J. T. van Dissel, and E. van de Vosse
IL-23 modulates CD56+/CD3- NK Cell and CD56+/CD3+ NK-like T Cell function differentially from IL-12
Int. Immunol., February 1, 2009; 21(2): 145 - 153.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020